98.27%
Lot
NOR-202608-138
Purity
98.55%
- Form
- Lyophilised powder
- Storage
- −20 °C, desiccated
- Stability
- 24 months
- CAS
- 158861-67-7
- Formula
- C45H55N9O6
- Molecular weight
- 817.97 g/mol
- Solubility
- Bacteriostatic water or 0.9% NaCl, ≥2 mg/mL
GHRP-2
Pralmorelin · growth hormone releasing peptide 2
£23
Vial massGHRP2-5-NOR
1
49 vials in stock · dispatched within 24 h
A synthetic hexapeptide ghrelin mimetic, one of the earliest characterised members of the GHRP series and a standard comparator in the class.
GHS-R1a agonismComparative GHRP panels
Supplied for laboratory research use only. Not for human or veterinary use, consumption, or clinical application.
Analysis
Certificate of analysis
RP-HPLC chromatogramJanoshik Analytical
Retention time (min)λ 214 nm
Purity98.55%
Specification ≥ 98.0%
- Lot
- NOR-202608-138
- Released
- 2026-08-10
- Mass expected
- 817.97 Da
- Mass found
- 817.97 Da
- Water (KF)
- 1.51%
- Endotoxin
- 0.086 EU/mg
- Appearance
- White lyophilisate
Primary structure
10 residues
Hover a residue for detail
- Formula
- C45H55N9O6
- Molecular weight
- 817.97 g/mol
Interactive
Reconstitution
Vial mass
mL
mcg
Syringe
- Draw to
- 10.0 units
- Volume
- 0.100 mL
- Concentration
- 2.50 mg/mL
- Draws per vial
- 20
Arithmetic for GHRP-2 at the values you entered. Not a protocol and not a dose recommendation. Research use only.
Handling
- On arrival
- Transfer to −20 °C within two hours. Vials ship on phase-change packs rated for 72 hours.
- Reconstitution
- Bacteriostatic water or 0.9% NaCl, ≥2 mg/mL
- After reconstitution
- 2–8 °C, use within 28 days. Aliquot to avoid freeze-thaw cycling.
- Shelf life
- 24 months lyophilised, desiccated and protected from light.